PFIZER INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PFIZER INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 4.00K shares, a 99.94% decline from fiscal 2023.
- PFIZER INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 6.71M shares, a 31.95% decline from fiscal 2022.
- PFIZER INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 9.86M shares, a 68.23% decline from fiscal 2021.
- PFIZER INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 31.04M shares, a 67.83% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 4.00K shares 10-K · filed 2025-02-27 | |
| 2023-12-31 | 6.71M shares 10-K · filed 2024-02-22 | |
| 2022-12-31 | 9.86M shares 10-K · filed 2023-02-23 | |
| 2021-12-31 | 31.04M shares 10-K · filed 2022-02-24 | |
| 2020-12-31 | 18.49M shares 10-K · filed 2021-02-25 | |
| 2019-12-31 | 15.96M shares 10-K · filed 2020-02-27 | |
| 2018-12-31 | 47.74M shares 10-K · filed 2019-02-28 | |
| 2017-12-31 | 34.69M shares 10-K · filed 2018-02-22 | |
| 2016-12-31 | 42.55M shares 10-K · filed 2017-02-23 | |
| 2015-12-31 | 56.89M shares 10-K · filed 2016-02-29 | |
| 2014-12-31 | 46.96M shares 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |